Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combining Medications to Enhance Depression Outcomes
NCT00590863Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Mar 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution, bupropion, venlafaxine, mirtazapine in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Mar 2008; status: completed.
02
Drugs
Escitalopram oxalate oral solutionbupropionvenlafaxinemirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00590863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590863.